A phase 1 trial of fosbretabulin in patients with gastrointestinal neuroendocrine tumors
Latest Information Update: 06 Aug 2015
At a glance
- Drugs Fosbretabulin (Primary)
- Indications Gastrointestinal cancer; Neuroendocrine tumours
- Focus Therapeutic Use
- 06 Aug 2015 New trial record